Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Tenax Therapeutics (TENX) Profit After Tax (2016 - 2017)

Tenax Therapeutics' Profit After Tax history spans 8 years, with the latest figure at -$16.3 million for Q4 2017.

  • For Q4 2017, Profit After Tax rose 51.75% year-over-year to -$16.3 million; the TTM value through Dec 2017 reached -$8.8 million, up 70.83%, while the annual FY2025 figure was -$52.6 million, 198.83% down from the prior year.
  • Profit After Tax for Q4 2017 was -$16.3 million at Tenax Therapeutics, down from $1.2 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $4.6 million in Q2 2016 and bottomed at -$115.2 million in Q1 2013.
  • The 5-year median for Profit After Tax is -$5.4 million (2016), against an average of -$17.2 million.
  • The largest annual shift saw Profit After Tax tumbled 1678.18% in 2013 before it soared 161.09% in 2017.
  • A 5-year view of Profit After Tax shows it stood at -$115.2 million in 2013, then skyrocketed by 89.21% to -$12.4 million in 2014, then crashed by 79.46% to -$22.3 million in 2015, then tumbled by 51.82% to -$33.9 million in 2016, then surged by 51.75% to -$16.3 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Profit After Tax are -$16.3 million (Q4 2017), $1.2 million (Q3 2017), and $3.0 million (Q2 2017).